>> Top Page >> Business Project >> Project Summary Disease Therapy HLA Type Total number of patients (Thousands) Number of target patients (Thousands) Stage Malignant Brain Tumor Personalized A24 2 0.4 (JP) Phase I (JP) Advanced Hormone-Refractory Prostate Cancer Personalized with Estramustine A24 20 4 (JP) Phase I (JP) A2 200 35 (US) In preparation